Skip to content

The Effectiveness, Brain Region Specificity and Cross-Frequency Coupling Mechanism of Temporal Interference Stimulation Intervention on Working Memory Deficits in Schizophrenia

The Effectiveness, Brain Region Specificity and Cross-Frequency Coupling Mechanism of Temporal Interference Stimulation Intervention on Working Memory Deficits in Schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106593
Enrollment
Unknown
Registered
2025-07-25
Start date
2025-07-29
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

TIs Group [4Hz]- IPL target group :Temporal Interference Stimulation (TIS) targeted IPL brain area
tACS Group [4Hz] - IPL target group :Transcranial Alternating Current Stimulation (tACS) targeted IPL brain area
TIs Sham Stimulation Group:Temporal Interference Stimulation-Sham, TI-Sham
tACS Sham Stimulation Group:Transcranial Alternating Current Stimulation-Sham, tACS-Sham
TIs Group [4Hz]- DLPFC target group :Temporal Interference Stimulation (TIS) targeted DLPFC brain area

Sponsors

Beijing Huilongguan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of DSM-5 schizophrenia; 2. Age 18-45 years old; 3. Years of education> = 6 years; 4. First onset, total disease course <=5 years; 5. Obvious working memory deficits: spatial breadth test <=5 points in the cognitive function kit (defined according to the mean of the Chinese norm -95% confidence interval); 6. The total cycle of previous systematic use of antipsychotics, antidepressants, emotional stabilizers and other psychotropic drugs <=2 weeks; 7. Right-handed; Normal vision and hearing (or corrected), no color blindness or color blindness, no communication disorders; 8. The patient's legal guardian and/or patient voluntarily participated in the study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Accompanied by mental retardation or other brain organic diseases, with an IQ of less than 85 points; 2. Severe recession or impulsive excitement and uncooperation; 3. Accompanied by severe depression, anxiety, and substance abuse (except tobacco); 4. Organic auditory or/visual perception impairment; 5. Non-unstable state, severe physical diseases or serious drug side effects (such as severe extrapyramidal reactions, tardive dyskinesia, etc.); 6. Pregnant or lactating women; 7. Taking immunomodulators, neurotrophics, antioxidants, etc. in the past 8 weeks; 8. Infectious diseases occurred in the past 2 weeks; 9. Received physical modulation therapy such as tDCS, tACS, TMS and non-convulsive electroconvulsive therapy in the past 6 months.

Design outcomes

Primary

MeasureTime frame
Schizophrenia Symptom Severity - Clinician-Rated Scale;Working Memory Task Behavioral Performance Assessment;

Secondary

MeasureTime frame
Severity of cognitive impairment;EEG activity;

Countries

China

Contacts

Public ContactDeng Hu

Beijing HuiLongGuan Hospital

denghu501@163.com+86 83024081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026